China BCT Pharmacy Group, Inc.

OTCPK:CNBI Stock Report

Market Cap: US$3.8k

China BCT Pharmacy Group Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Huitian Tang

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure13.8yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure13.3yrs

Recent management updates

No updates

Recent updates

No updates


CEO

Huitian Tang (61 yo)

13.8yrs

Tenure

US$425,885

Compensation

Mr. Huitian Tang has been the Chairman and Chief Executive Officer of China BCT Pharmacy Group, Inc. since January 14, 2010 and December 30, 2009 respectively. Mr. Tang has been the President of Liuzhou Ba...


Board Members

NamePositionTenureCompensationOwnership
Huitian Tang
Chairman of the Board and Chief Executive Officer13.8yrsUS$425.89kno data
Xiaoyan Zhang
Chief Financial Officer13.8yrsUS$325.02kno data
Kam Cheung Chin
Independent Directorno dataUS$16.78kno data
Yunli Lou
Director12.6yrsno datano data
Man Wai Chiu
Independent Director13.3yrsUS$16.78kno data
Hon Keung Choi
Independent Director13.3yrsUS$16.78kno data

13.3yrs

Average Tenure

61yo

Average Age

Experienced Board: CNBI's board of directors are seasoned and experienced ( 13.3 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.